SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway
Open Access
- 18 December 2014
- journal article
- Published by Wiley in The Journal of Pathology
- Vol. 235 (4), 559-570
- https://doi.org/10.1002/path.4482
Abstract
We investigated the oncogenic role of SETDB1, focusing on non-small cell lung cancer (NSCLC), which has high expression of this protein. A total of 387 lung cancer cases were examined by immunohistochemistry; 72% of NSCLC samples were positive for SETDB1 staining, compared to 46% samples of normal bronchial epithelium (106 cases) (p <0.0001). The percentage of positive cells and the intensity of staining increased significantly with increased grade of disease. Forced expression of SETDB1 in NSCLC cell lines enhanced their clonogenic growth in vitro and markedly increased tumour size in a murine xenograft model, while silencing (shRNA) SETDB1 in NSCLC cells slowed their proliferation. SETDB1 positively stimulated activity of the WNT-β-catenin pathway and diminished P53 expression, resulting in enhanced NSCLC growth in vitro and in vivo. Our finding suggests that therapeutic targeting of SETDB1 may benefit patients whose tumours express high levels of SETDB1.Funding Information
- National Institutes of Health (R01CA026038-35)
This publication has 50 references indexed in Scilit:
- Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast CancersMolecular Cell, 2011
- The HP1α–CAF1–SetDB1‐containing complex provides H3K9me1 for Suv39‐mediated K9me3 in pericentric heterochromatinEMBO Reports, 2009
- The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathwayOncogene, 2009
- A mouse model for EML4-ALK -positive lung cancerProceedings of the National Academy of Sciences of the United States of America, 2008
- Increased Prevalence ofEGFR-Mutant Lung Cancer in Women and in East Asian Populations: Analysis of Estrogen-Related PolymorphismsClinical Cancer Research, 2008
- Covalent modifications of histones during development and disease pathogenesisNature Structural & Molecular Biology, 2007
- Targeting the active β-catenin pathway to treat cancer cellsMolecular Cancer Therapeutics, 2006
- Chromatin Modifications by Methylation and Ubiquitination: Implications in the Regulation of Gene ExpressionAnnual Review of Biochemistry, 2006
- Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cellsJournal of Neurochemistry, 2006
- Wnt Signaling in Stem Cells and Non–Small-Cell Lung CancerClinical Lung Cancer, 2005